The management of chronic heart failure, following current guidelines, requires the implementation and adjustment of therapies to limit mortality and morbidity associated with disease progression. However, this period of treatment titration remains challenging due to the need for multiple, closely spaced consultations. The difficulty in maintaining this consultation frequency, coupled with the current decline in medical demographics, largely explains the lack of treatment titration or even initiation and the existing therapeutic inertia. Concurrently, medical telemonitoring is emerging as an essential tool in heart failure management, offering significant benefits for both patients and healthcare professionals. In this context, new forms of nursing practices have emerged, such as advanced practice nursing, aimed at improving the care of patients with chronic diseases. However, only limited data are currently available regarding the functioning and impact of these consultations in France. The "Evaluation and Support Pathway for Heart Failure Patients (FIL-EAS ic)" has systematically integrated this new model of consultations provided by heart failure nurse specialists. Given their significant and growing role within the pathway, it appears necessary to thoroughly evaluate these consultations to propose improvements and maximize their effectiveness.
Study Type
OBSERVATIONAL
Enrollment
137
Heart Failure Specialist Nurses consultations
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Toulon, Var, France
Type of consultation
Medical telemonitoring, treatment titration, advanced practice nurse follow-up
Time frame: 1-year period
Patient's medical history
Patient's clinical characteristics will be analyzed : number and type of medical histories
Time frame: 1-year period
Treatments implemented
Type and dose of treatment initiated for heart failure will be analyzed.
Time frame: 1-year period
Number of consultations
The number of consultations will be analyzed by type of activity (medical telemonitoring, treatment titration, advanced practice nurse follow-up).
Time frame: 1-year period
Number of hospitalizations
The number of hospitalizations and re-hospitalizations during the 12 months of follow-up will be analyzed.
Time frame: 1-year period
Type of referral
The type of referral will be analyzed : in-hospital (cardiology or non-cardiology) or out-of-hospital (cardiologist, general practitioner, private nurse or Advanced Practice Registered Nurse)
Time frame: 1-year period
Reason for discontinuation of titration consultation
The reason for the discontinuation of titration consultations will be analyzed.
Time frame: 1-year period
Left ventricular ejection fraction (LVEF)
Echocardiography data during therapy titration will be analyzed.
Time frame: 1-year period
Modification of recommended treatment doses
Modification of recommended treatment doses in heart failure will be analyzed in the overall cohort and according to the level of LVEF at initial management.
Time frame: 1-year period
Rate of detection of iron deficiency
The rate of detection of iron deficiency will be analyzed according to whether or not Ferinject supplementation is used.
Time frame: 1-year period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.